Induction of directional sprouting angiogenesis by matrix gradients

Journal of Biomedical Materials Research - Part A

Volumn 80, Issue 2, 2007, Pages 297-305

  Borselli, Cristina ^a   Oliviero, Olimpia ^a   Battista, Sabrina ^b   Ambrosio, Luigi ^b   Netti, Paolo A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

Collagen; Hyaluronic acid; Semi interpenetrated network; Sprouting angiogenesis; Tissue regeneration

Indexed keywords

CELLS; COLLAGEN; OXYGEN SUPPLY; TISSUE CULTURE;

HYALURONIC ACID; SEMI-INTERPENETRATED NETWORK; SPROUTING ANGIOGENESIS; TISSUE REGENERATION; VASCULARIZATION;

BIOMEDICAL ENGINEERING;

COLLAGEN; HYALURONIC ACID;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; EXTRACELLULAR MATRIX; FEASIBILITY STUDY; IMPLANT; NONHUMAN; NUTRIENT SUPPLY; OXYGEN SUPPLY; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; CATTLE; COLLAGEN; CULTURE MEDIA; HYALURONIC ACID; KINETICS; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING;

EID: 33846401173     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30896     Document Type: Article

References (43)

1. Tabata Y, Miyao M, Yamamoto M, Ikada Y. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. J Biomater Sci Polym Ed 1999;10:957-968.
2. King TW, Patrick CW. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation /single emulsion/solvent extraction technique. J Biomed Mater Res 2000;1:383-390.
3. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001;19:1029-1034.
4. Ruoslahti E. RGD and other recognition sequences for integrins. Ann Rev Cell Dev Biol 1996;12:697-715.
5. Hubbell JA. Bioactive biomaterials. Curr Opin Biotechnol 1999;10:123-129.
6. Pieper JS, van Wachem PB, van Luyn MJA, Brouwer LA, Hafmans T, Veerkamp JH, van Kuppevelt TH. Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats. Biomaterials 2000;21:1689-1699.
7. Whitaker MJ, Quirk RA, Howdle SM, Shakesheff KM. Growth factor release from tissue engineering scaffolds. J Pharm Pharmacol 2001;53:1427-1437.
8. Lutolf MP, Lauer-Fields JL, Schmoekel HG, Metters AT, Weber FE, Fields GB, Hubbell JA. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics. Proc Natl Acad Sci USA 2003;29:100:5413-5418.
9. Zisch AH, Lutolf MP, Hubbell JA. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 2003;12:295-310.
10. Ehrbar M, Djonov VG, Schnell C, Tschanz SA, Martiny-Baron G, Schenk U, Wood J, Burri PH, Hubbell JA, Zisch AH. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 2004;94:1124-1132.
11. Koike N, Fukumura D, Gralla O, Au P, Schechner JS, Jain RK. Tissue engineering: Creation of long-lasting blood vessels: Nature 2004;11:428:138,139.
12. Carmeliet P, Conway EM. Growing better blood vessels. Nat Biotechnol 2001;19:1019,1020.
13. Malinda KM, Nomizu M, Chung M, Delgado M, Kuratomi Y, Yamada Y, Kleinman HK, Ponce ML. Identification of laminin α1 and β1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J 1999;13:53-62.
14. Zisch AH, Lutolf MP, Ehrbar M, Raeber GP, Rizzi SC, Davies N, Schmokel H, Bezuidenhout D, Djonov V, Zilla P, Hubbell JA. Cell demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth. FASEB J 2003;17:2260-2262.
15. Fittkau MH, Zilla P, Bezuidenhout D, Lutolf MP, Human P, Hubbell JA, Davies N. The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides. Biomaterials 2005;26:167-174.
16. Akeson AL, Greenberg JM, Cameron JE, Thompson FY, Brooks SK, Wiginton D, Whitsett JA. Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung. Dev Biol 2003;264:443-455.
17. Xin X, Borzacchiello A, Netti PA, Ambrosio L, Nicolais L. Hyaluronic-acid-based semiinterpenetrating materials. J Biomater Sci Polym Ed 2004;15:1223-1236.
18. Korff T, Augustin HG. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 1998;143:1341-1352.
19. Pepper MS. Positive and negative regulation of angiogenesis: From cell biology to the clinic. Vasc Med 1996;1:259-266.
20. Sage EH, Vernon RB. Regulation of angiogenesis by extracellular matrix: The growth and the glue. J Hypertens Suppl 1994;12:S145-S152.
21. Folkman J. Angiogenesis: Initiation and control. Ann NY Acad Sci 1982;401:212-227.
22. Srupack DG, Cheresh DA. ECM remodeling regulates angiogenesis: Endothelial integrins look for new ligands. Sci STKE 2002 (119):PE7.
23. Jiang B, Liou GI, Behzadian MA, Calwell RB. Astrocytes modulate retinal vasculogenesis: Effects on fibronectin expression. J Cell Sci 1994;107:2499-2508.
24. Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, Sobel M. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 2002;91:25-31.
25. Rapraeger AC. Syndecan-regulated receptor signaling. J Cell Biol 2000;149:995-998.
26. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
27. Brecht M, Mayer U, Schlosser E, Prehm P. Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J 1986;239:445-450.
28. Goldberg RL, Toole BP. Hyaluronate inihition of cell proliferation. Arthritis Rheum 1987;30:769-778.
29. Toole BP. Proteoglycans and HA in morphogenesis and differentiation. In: Hay ED, editor. Cell Biology of the Extracellular Matrix, 2nd ed. New York: Plenum; 1991. pp 305-341.
30. Whelan MC, Senger DR. Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J Biol Chem 2003;278:327-334.
31. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;6:2397-2404.
32. Rooney P, Kumar S. Inverse relationship between hyaluronan and collagens in development and angiogenesis. Differentiation 1993;54:1-9.
33. Sage EH, Reed M, Funk SE, Truong T, Steadele M, Puolakkainen P, Maurice DH, Bassuk JA. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem 2003;278:37849-37857.
34. Davies C de L, Melder RJ, Munn LL, Mouta-Carreira C, Jain RK, Boucher Y. Decorin inhibits endothelial migration and tube-like structure formation: Role of thrombospondin-1. Microvasc Res 2001;62:26-42.
35. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990;87:6624-6628.
36. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993;122:497-511.
37. Volpert OV, Lawler J, Bouck NP. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc Natl Acad Sc USA 1998;95:6343-6348.
38. West DC, Kumar S. The effect of hyaluronan and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989;183:179-196.
39. West DC, Shaw DM. Tumour HA in relation to angiogenesis and metastasis. In:Laurent TC, editor. The Chemistry, Biology and Medical Applications of HA and its Derivatives. London: Portland Press; 1998. pp 227-233. Werner-Gren international Series No. 72.
40. Toole BP, Biswas C, Gross J. Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci USA 1979;76:6299-6303.
41. Dorrell MI, Aguilar E, Friedlander M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest Ophthalmol Vis Sci 2002, 43:3500-3510.
42. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, Betsholtz C, Shima DT. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002;16:2684-2698.
43. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003;161:1163-1177.